STATUS QWO : CELLULITE HAS MET ITS MATCH WITH A NEW INJECTIBLE
Photo Credit: pexels.com
Cellulilte is one of those topics that most of us in the aesthetics space tend to be leery of. We’ve heard it all before; reduces dimples, pulverizes lumps and bumps, smooths skin, yada, yada, yada. These miracle cures often come with some discomfort, more downtime than expected, a longterm commitment to maintain the improvement, and a hefty price tag. Nonetheless, ‘cellulite’ continues to be a beauty buzzword that gets our attention because 80-90 percent of women, depending on who you ask, have it somewhere.
Enter QWO
The long awaited first-ever cellulite injectable, called QWO from Endo Pharmaceuticals (collagenase clostridium histolyticum-aaes) now has FDA approval, and the data is
THE LATEST WEAPON IN THE FIGHT AGAINST CELLULITE
Photo Credit: Pexels.com
The term cellulite was penned in the 1960s, from the French word cellule or ‘small cell.’ Leave it to the French to put a name to what most women (or like 99%) experience at some point in their lives. The prevalence of these estrogen-related lumps and bumps makes them no less frustrating. There’s no shortage of purported solutions—ranging from creams and lotions to office-based treatments—but none have proven to be a “magic bullet” that improves the appearance of cellulite for the long-term.
Based on the proven effectiveness of its muscle-sculpting sibling, EmSculpt, the launch of BTL’s Emtone is poised to change the cellulite game. According to Miami dermatologist Dr. Mariano
